WallStreetZenWallStreetZen

NASDAQ: TGTX
Tg Therapeutics Inc Stock Ownership - Who owns Tg Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Tg Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sagar LonialDirector2024-06-2016,348$16.87
$275.79kSell
Sagar LonialDirector2024-06-179,585$16.39
$157.10kSell
Sagar LonialDirector2024-03-135,000$15.94
$79.68kSell
Laurence N. CharneyDirector2024-03-1222,000$15.97
$351.34kSell
Laurence N. CharneyDirector2024-01-0517,500$19.03
$333.03kSell
Sean A. PowerCFO2024-01-0347,867$16.91
$809.43kSell

1 of 1

TGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TGTX insiders and whales buy or sell their stock.

TGTX Shareholders

What type of owners hold Tg Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Michael S. Weiss23.94%37,057,818$816.38MInsider
Vanguard Group Inc8.84%13,691,690$301.63MInstitution
Ra Capital Management LP8.16%12,629,868$278.24MInsider
Blackrock Inc7.36%11,388,346$250.89MInstitution
Lindsay A. Md Rosenwald6.11%9,462,616$208.46MInsider
Biotechnologies Sasu Lfb4.92%7,614,855$167.76MInsider
State Street Corp4.33%6,696,143$147.52MInstitution
Joan Pons Gimbert2.56%3,959,149$87.22MInsider
Soleus Capital Management LP2.35%3,645,562$80.31MInstitution
Pictet Asset Management Holding Sa2.09%3,243,481$71.45MInstitution

1 of 3

TGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TGTX54.54%45.46%Net SellingNet Selling
MRUS89.68%10.32%Net SellingNet Selling
FOLD66.29%33.71%Net SellingNet Selling
BHVN81.23%18.77%Net BuyingNet Buying
DYN73.12%26.88%Net SellingNet Selling
View Top Biotech Stocks

Tg Therapeutics Stock Ownership FAQ

Who owns Tg Therapeutics?

Tg Therapeutics (NASDAQ: TGTX) is owned by 60.26% institutional shareholders, 50.23% Tg Therapeutics insiders, and 0.00% retail investors. Michael S. Weiss is the largest individual Tg Therapeutics shareholder, owning 37.06M shares representing 23.94% of the company. Michael S. Weiss's Tg Therapeutics shares are currently valued at $816.38M.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.